ICON Cost of Goods Sold 2010-2025 | ICLR
ICON annual/quarterly cost of goods sold history and growth rate from 2010 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- ICON cost of goods sold for the quarter ending March 31, 2025 was $1.443B, a 1.95% decline year-over-year.
- ICON cost of goods sold for the twelve months ending March 31, 2025 was $5.817B, a 0.36% increase year-over-year.
- ICON annual cost of goods sold for 2024 was $5.845B, a 2.19% increase from 2023.
- ICON annual cost of goods sold for 2023 was $5.72B, a 3.49% increase from 2022.
- ICON annual cost of goods sold for 2022 was $5.527B, a 39.13% increase from 2021.
| ICON Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $5,845 |
| 2023 | $5,720 |
| 2022 | $5,527 |
| 2021 | $3,973 |
| 2020 | $1,980 |
| 2019 | $1,974 |
| 2018 | $1,818 |
| 2017 | $1,027 |
| 2016 | $961 |
| 2015 | $909 |
| 2014 | $903 |
| 2013 | $845 |
| 2012 | $718 |
| 2011 | $612 |
| 2010 | $541 |
| 2009 | $508 |
| ICON Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,443 |
| 2024-12-31 | $1,442 |
| 2024-09-30 | $1,439 |
| 2024-06-30 | $1,494 |
| 2024-03-31 | $1,471 |
| 2023-12-31 | $1,446 |
| 2023-09-30 | $1,449 |
| 2023-06-30 | $1,430 |
| 2023-03-31 | $1,396 |
| 2022-12-31 | $1,381 |
| 2022-09-30 | $1,376 |
| 2022-06-30 | $1,392 |
| 2022-03-31 | $1,378 |
| 2021-12-31 | $1,357 |
| 2021-09-30 | $1,358 |
| 2021-06-30 | $631 |
| 2021-03-31 | $626 |
| 2020-12-31 | $535 |
| 2020-09-30 | $493 |
| 2020-06-30 | $446 |
| 2020-03-31 | $505 |
| 2019-12-31 | $508 |
| 2019-09-30 | $500 |
| 2019-06-30 | $491 |
| 2019-03-31 | $475 |
| 2018-12-31 | $479 |
| 2018-09-30 | $459 |
| 2018-06-30 | $449 |
| 2018-03-31 | $431 |
| 2017-12-31 | $267 |
| 2017-09-30 | $260 |
| 2017-06-30 | $250 |
| 2017-03-31 | $250 |
| 2016-12-31 | $252 |
| 2016-09-30 | $243 |
| 2016-06-30 | $238 |
| 2016-03-31 | $229 |
| 2015-12-31 | $229 |
| 2015-09-30 | $227 |
| 2015-06-30 | $225 |
| 2015-03-31 | $228 |
| 2014-12-31 | $230 |
| 2014-09-30 | $230 |
| 2014-06-30 | $227 |
| 2014-03-31 | $216 |
| 2013-12-31 | $215 |
| 2013-09-30 | $214 |
| 2013-06-30 | $214 |
| 2013-03-31 | $202 |
| 2012-12-31 | $192 |
| 2012-09-30 | $183 |
| 2012-06-30 | $180 |
| 2012-03-31 | $162 |
| 2011-12-31 | $158 |
| 2011-09-30 | $158 |
| 2011-06-30 | $151 |
| 2011-03-31 | $144 |
| 2010-12-31 | $140 |
| 2010-09-30 | $139 |
| 2010-06-30 | $131 |
| 2010-03-31 | $131 |
| 2009-12-31 | $131 |
| 2009-09-30 | $127 |
| 2009-06-30 | $125 |
| 2009-03-31 | $124 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.521B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.906B | 25.49 |
| Elevance Health (ELV) | United States | $86.723B | 11.19 |
| CVS Health (CVS) | United States | $81.012B | 10.07 |
| Cencora (COR) | United States | $56.449B | 19.64 |
| DiDi Global (DIDIY) | China | $21.556B | 32.71 |
| Natera (NTRA) | United States | $21.537B | 0.00 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.928B | 0.00 |
| Solventum (SOLV) | United States | $12.646B | 13.39 |
| CochLear (CHEOY) | Australia | $11.378B | 0.00 |
| Revvity (RVTY) | United States | $10.658B | 18.34 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Doximity (DOCS) | United States | $9.784B | 45.30 |
| Avantor (AVTR) | United States | $8.797B | 12.78 |
| HealthEquity (HQY) | United States | $8.702B | 42.81 |
| Medpace Holdings (MEDP) | United States | $8.476B | 22.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.311B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.662B | 13.05 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.149B | 38.40 |
| Bausch + Lomb (BLCO) | Canada | $4.054B | 23.90 |
| Sotera Health (SHC) | United States | $3.474B | 19.74 |
| Alignment Healthcare (ALHC) | United States | $3.041B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.026B | 39.35 |
| Concentras Parent (CON) | United States | $2.772B | 16.02 |
| Organon (OGN) | United States | $2.397B | 2.55 |
| Ardent Health Partners (ARDT) | United States | $2.071B | 8.83 |
| GeneDx Holdings (WGS) | United States | $2.032B | 78.26 |
| Premier (PINC) | United States | $1.892B | 14.36 |
| Progyny (PGNY) | United States | $1.843B | 40.57 |
| PACS (PACS) | United States | $1.512B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.400B | 28.00 |
| Pediatrix Medical (MD) | United States | $1.216B | 9.25 |
| Teladoc Health (TDOC) | United States | $1.214B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.995B | 0.00 | |
| CareDx (CDNA) | United States | $0.946B | 14.77 |
| Nutex Health (NUTX) | United States | $0.934B | 14.11 |
| Agilon Health (AGL) | United States | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.808B | 7.57 |
| Embecta (EMBC) | United States | $0.615B | 4.15 |
| LifeMD (LFMD) | United States | $0.555B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 43.75 |
| SBC Medicals (SBC) | United States | $0.532B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.67 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.389B | 0.00 |
| Oncology Institute (TOI) | United States | $0.285B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| KindlyMD (NAKA) | United States | $0.136B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.112B | 0.00 |
| OncoCyte (OCX) | United States | $0.095B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| ModivCare (MODV) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |